Kotak Mahindra Mutual Fund Increases Stake in Molbio Diagnostics Beyond 5%
Molbio Diagnostics Ltd · Acquisition/ Disposal of Shares · 13 Oct 2026, 3:52 pm
Kotak Mahindra Mutual Fund Increases Stake in Molbio Diagnostics Beyond 5% Kotak Mahindra Mutual Fund acquired 570,000 equity shares (a 0.4946% stake) of Molbio Diagnostics Limited via open market purchases on 8th Oct'26. Following this transaction, the fund's aggregate holding increased from 5,749,083 shares (4.9888%) to 6,319,083 shares, representing 5.4834% of the company's total equity share and voting capital. Molbio Diagnostics' total paid-up equity base stands unchanged at 11,52,39,996 shares of ₹1 face value each.
Original exchange filing (PDF)
More announcements from Molbio Diagnostics Ltd
- Transcript of Earnings Call with analysts and investors for the quarter and half year ended on September 30, 2026 · 11 Nov 2026
- Monitoring Agency Report on the utilization of proceeds raised through issuance of equity shares by way of Public Issue of the Company · 07 Nov 2026
- Audio Recording of Earnings call held on November 05,2026 for the quarter and half year ended September 30,2026. · 06 Nov 2026
- Outcome of Board meeting held on Thursday, November 05, 2026 · 06 Nov 2026
- Investor presentation · 05 Nov 2026
- Outcome of the Board Meeting · 05 Nov 2026
- Molbio Diagnostics Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 05 Nov 2026
- Intimation of Earnings Conference Call on November 05, 2026, at 05:30 P.M. IST to discuss the financial performance of the Company for the quarter and half year ended September 30, 2026. · 05 Nov 2026
